Category : Search result: 500 crore deals


AI Stocks Wobble, But 2026 Outlook Stays Positive

Wall Street's AI stocks face volatility amid capex and competition fears. Yet, experts like 22V Research's Dennis DeBusschere see long-term gains, with HSBC predicting major S&P 500 cost savings from AI adoption. Read more.

Force Motors Multibagger: 8000% Return Since 2013

Force Motors shares have delivered phenomenal multibagger returns, surging 164% in one year and 340% in two years. Discover the financial performance and growth story behind this auto stock.

Corporate America Q3 2023 Performance Analysis

Corporate America shows resilience in Q3 2023 with strong earnings despite economic challenges. Discover key trends, sector performance, and future outlook for US companies.

US Stock Market Crash Fears: Experts Divided

Is the US stock market heading for a crash? Experts are divided as S&P 500 gains 16% and Nasdaq surges 20% YTD. Learn about the risks and opportunities for Indian investors.

Avatar 3 Targets Rs 500 Crore Record in India

James Cameron's 'Avatar: Fire and Ash' eyes a historic Rs 500 crore collection in India. With 1.2 million advance interests, it could surpass Avengers: Endgame. Releasing December 19.

Wall Street Indices Mixed in Early Trading

Wall Street's key indices showed a mixed trend as investors analyzed delayed economic reports. The Dow rose slightly while S&P 500 and Nasdaq fell. Discover how tech giants performed.

OpenAI Teams With Foxconn for $500B AI Project

OpenAI partners with Foxconn to build $500B AI infrastructure including custom chips and data centers. Bezos's Prometheus challenges xAI in escalating AI talent war. Read more!

OpenAI Teams With Foxconn for $500B AI Project

OpenAI partners with Foxconn to build $500B AI infrastructure including custom chips and data centers. Bezos's Prometheus challenges xAI in escalating AI talent war. Read more!

US Stocks Rally on December Rate Cut Expectations

US markets opened stronger amid Federal Reserve rate cut expectations. S&P 500 advanced 0.7%, Nasdaq climbed 1.1% despite Novo Nordisk setback. Full analysis of global market trends.

Page 1 of 4